Goodwin Procter has advised Parabilis Medicines. Covington has advised the underwriters. Parabilis Medicines, Inc., a clinical-stage biopharmaceutical company, has completed an upsized initial public offering, raising...
Parabilis Medicines Completes $770 Million Upsized IPO and $75 Million Private Placement
DoorDash Acquires SevenRooms in $1.2 Billion Deal
Weil, Gotshal & Manges has advised PSG; Goodwin has advised SevenRooms; A&O Shearman has advised DoorDash. PSG has finalized the sale of SevenRooms, a prominent New...
Kyowa Kirin’s $387 Million Acquisition of Orchard Therapeutics
Kyowa Kirin was represented by Goldman Sachs Japan Co., Ltd. as financial advisor and Morrison & Foerster LLP. as legal advisor. Orchard Therapeutics was represented by...
Korro Bio and Frequency Therapeutics’ Merger Agreement
Goodwin Procter is serving as legal counsel to Korro Bio, Latham & Watkins is serving as Frequency Therapeutics’ legal counsel, and Davis Polk is serving as...
Coherus’ Acquisition of Surface Oncology
Arnold & Porter advised Coherus Biosciences Inc. on the deal, and Goodwin advised Surface Oncology. Coherus Biosciences Inc. (Coherus) announced its acquisition of Surface Oncology Inc. (Surface),...
E. & J. Gallo Winery’s Acquisition of Bev
Goodwin advised Bev on the deal. E. & J. Gallo Winery announced that it acquired Bev and its portfolio of premium canned wines and spritzers. The acquisition...
Latch’s Acquisition of Honest Day’s Work
Goodwin advised Honest Day’s Work on the deal. Latch, Inc. (NASDAQ: LTCH) announced that it has entered into a definitive agreement to acquire Honest Day’s Work...